Scientists have used synthetic antibodies to block cell receptors in the liver that normally bind to glucagon, a hormone involved in increasing the amount of glucose in the blood. The antibodies restored normal blood glucose levels in three different mouse models of diabetes. The treatment partly worked by transforming alpha cells in the pancreas into […]
The study could lead to the development of more personalized interventions that prevent at-risk individuals from developing type 2 diabetes. People with prediabetes have consistently high blood sugar levels but have yet to develop the symptoms of type 2 diabetes. Over many years, the cells of people with this condition become increasingly resistant to the […]
